Showing results (301-310 of 323) with videos related to
Sort By:
Pageof 33
Cell Chemical Biology|December 30, 2019
Exploring Targeted Degradation Strategy for Oncogenic KRASG12CMei Zeng, Yuan Xiong, Nozhat Safaee, et al.Cell Chemical Biology|August 8, 2017
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12CMei Zeng, Jia Lu, Lianbo Li, et al.Nature Chemical Biology|August 11, 2025
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDACNathan L Tran, Jiewei Jiang, Min Ma, et al.BMJ Open|July 1, 2024
Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trialGillian Doe, Ethaar El-Emir, George D Edwards, et al.Elife|January 30, 2018
Prediction of enzymatic pathways by integrative pathway mappingSara Calhoun, Magdalena Korczynska, Daniel J Wichelecki, et al.Cancer Cell|March 5, 2019
Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate CancerMiguel Reina-Campos, Juan F Linares, Angeles Duran, et al.Molecular Cell|November 25, 2022
The miniature CRISPR-Cas12m effector binds DNA to block transcriptionWen Y Wu, Prarthana Mohanraju, Chunyu Liao, et al.Journal of Medicinal Chemistry|July 24, 2008
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinasesTao Wang, Michelle L Lamb, David A Scott, et al.Cancer Research|October 10, 2018
Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast CancerZebin Wang, Shaun E Grosskurth, Tony Cheung, et al.Journal of Medicinal Chemistry|December 3, 2024
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase InhibitorsFlorian Wittlinger, Surbhi P Chitnis, Calvin D Pham, et al.Pageof 33